EP Patent

EP0165775A1 — Antifungal azole compounds

Assigned to Imperial Chemical Industries Ltd · Expires 1985-12-27 · 40y expired

What this patent protects

A 1-azolylmethyl-2-halogenoazolyl-1-(optionally- substituted phenyl)ethanol, wherein the azolyl groups are imidazolyl or 1,2,4-triazolyl and the optional substituent in the phenyl group is halogen, cyano, alkyl, alkoxy, halogenoalkyl, halogenoalkoxy, alkylsulphonyl, alkylamino, d…

USPTO Abstract

A 1-azolylmethyl-2-halogenoazolyl-1-(optionally- substituted phenyl)ethanol, wherein the azolyl groups are imidazolyl or 1,2,4-triazolyl and the optional substituent in the phenyl group is halogen, cyano, alkyl, alkoxy, halogenoalkyl, halogenoalkoxy, alkylsulphonyl, alkylamino, dialky- lamino, phenyl, halogenophenyl, phenoxy or halogenophenoxy, processes for its manufacture and antifungal compositions containing said compound.

Drugs covered by this patent

Patent Metadata

Patent number
EP0165775A1
Jurisdiction
EP
Classification
—
Expires
1985-12-27
Drug substance claim
No
Drug product claim
No
Assignee
Imperial Chemical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.